Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
35 studies found for:    " July 22, 2009":" August 21, 2009"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Rank Status Study
21 Completed TMC114-C201: A Study to Determine the Antiviral Activity of TMC114 in Patients With Multiple Protease Inhibitor (PI) Resistant Human Immunodeficiency Virus (HIV) Strains
Condition: HIV Infections
Intervention: Drug: TMC114
22 Completed Molecular Biology of Anal Cancer in HIV-Positive Patients
Conditions: Carcinoma;   HIV Infections
Intervention:
23 Completed Interaction Between Fosamprenavir/Ritonavir and a Single-dose Olanzapine (FORZA)
Condition: HIV Infections
Interventions: Drug: fosamprenavir/ritonavir;   Drug: olanzapine
24 Completed Evaluation of a Lopinavir/Ritonavir Monotherapy vs a Triple Therapy as Maintenance Regimens in HIV-1 Infected Patients
Condition: HIV Infections
Interventions: Drug: efavirenz/emtricitabin/tenofovir;   Drug: lopinavir/ritonavir
25 Unknown  Reducing HIV Risks in African American Teens
Condition: HIV Infections
Intervention: Behavioral: Healthy Futures parent education
26 Completed Evaluating the Pharmacokinetics of 400 mg Oral Dose of Raltegravir in HIV-Infected Pre-Menopausal Women
Condition: HIV Infections
Intervention:
27 Completed Therapy Targeting Depression and HIV Treatment Adherence (The TRIAD Study)
Conditions: HIV;   Depression;   HIV Infections
Interventions: Behavioral: Cognitive behavioral therapy (CBT) for adherence and depression (CBT-AD);   Behavioral: Life-steps adherence treatment;   Behavioral: Information and supportive psychotherapy (ISP) for adherence and depression (ISP-AD)
28 Completed Raltegravir Switch for Toxicity or Adverse Events
Conditions: HIV/AIDS;   Antiretroviral Therapy;   HIV Infections
Interventions: Drug: tenofovir emtricitabine raltegravir;   Drug: Lamivudine Abacavir Raltegravir;   Drug: Abacavir free
29 Completed
Has Results
Safety and Immunogenicity of 13-Valent Pneumococcal Conjugate Vaccine (13vPnC) in HIV-Infected Subjects 6 Years of Age or Older Who Are Naive to Pneumococcal Vaccine
Conditions: HIV Infections;   Pneumococcal Infections
Interventions: Biological: 13-valent Pneumococcal Conjugate Vaccine (13vPnC);   Biological: 23-valent Pneumococcal Polysaccharide Vaccine (23vPS);   Procedure: Blood draw
30 Completed
Has Results
Safety & Immunogenicity of 13vPnC in HIV-Infected Subjects Aged 18 or Older Who Were Previously Immunized With 23vPS
Conditions: HIV Infections;   Pneumococcal Infections
Interventions: Biological: 13-valent pneumococcal conjugate vaccine;   Procedure: Blood draw
31 Unknown  Genotypic Resistant HIV Strains in Taiwan
Conditions: HIV-1;   HIV Infections
Intervention:
32 Completed
Has Results
Switch From Combivir or Trizivir to Truvada - Mitochondrial Effects
Condition: HIV
Interventions: Drug: Truvada;   Drug: Combivir;   Drug: Trizivir
33 Completed Faster Identification of TB and Evaluation of Drug Resistance in HIV-infected People
Condition: HIV Infections
Intervention:
34 Completed Assessing HIV-Related Oral Mucosal Disease and Using Saliva to Measure Viral Load
Condition: HIV Infections
Intervention:
35 Active, not recruiting Comparing Two Types of Swabs in Collecting Cell Samples for Anal Pap Tests and Human Papillomavirus Tests in Men Who Have Sex With Men
Conditions: Anal Cancer;   Nonneoplastic Condition;   Precancerous Condition
Intervention: Other: Papanicolaou test

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-35) Next Page   
Indicates status has not been verified in more than two years